Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Aug 11, 2026

Lantheus Holdings, Inc. (LNTH)

A forensic read on Lantheus Holdings, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

C · Mixed — selective

Forensic grade

Safe

Financial health

9.7

Distress distance

Clean

Earnings quality

Forensic signals

23.6

P / E (ttm)

21.4%

ROE

$6.6B

Market cap

0.5%

Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Lantheus Holdings, Inc. earns a C (Mixed — selective) forensic quality grade, and its balance-sheet distress test reads 9.7, placing it in the Safe zone. 1 forensic signal was flagged in its latest SEC filings, led by accruals ratio (% of noa).

What the filings flag

+54.7%

FY2024→FY2025

Accruals ratio (% of NOA). Net operating assets grew +54.7% relative to their own average in FY2025 — scaled by NOA itself, not total assets (see the Forensic Screens card's differently-scaled Sloan Accrual Ratio for that read). Accruals are building sharply — a large slice of profit sits in operating assets, not cash; Richardson/Sloan link high accruals to weaker future returns as they reverse. The build is led by receivables up +12% against revenue +1%. This is the third straight fiscal year of building accruals — a multi-year streak is a materially stronger tell than a single year's move. The cash-flow cross-check is more mixed: reported earnings ran behind operating cash by 15% of net operating assets, diverging from the balance-sheet accrual read.

Key fundamentals

Latest Revenue$1.54B

Revenue Growth YoY+0.5%

Revenue CAGR (3yr)+18.1%

Net Margin15.2%

Free Cash Flow$390.1M

Return on Equity21.4%

Debt / Equity0.52x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Lantheus Holdings, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Aug 11, 2026. Forensic signals flag probability, not certainty.